Shoulder patient specific instrument

Information

  • Patent Grant
  • 12097129
  • Patent Number
    12,097,129
  • Date Filed
    Wednesday, October 20, 2021
    3 years ago
  • Date Issued
    Tuesday, September 24, 2024
    4 months ago
Abstract
A method of guiding a glenoid prosthesis is disclosed. The method includes preoperatively determining a position and an orientation of a guide feature of a glenoid guide of the present disclosure based on a scapula of a specific patient, and engaging the glenoid guide with the scapula; and inserting a pin having an axis through the guide feature to or through the scapula.
Description
BACKGROUND
Field of the Invention

The present invention relates to shoulder implants. In particular, the present invention relates to glenoid implants for shoulder joints having scapula erosion and devices that facilitate implanting the same.


Description of the Related Art

In a healthy shoulder joint, the head of the humerus interacts with the glenoid cavity of the scapula to form a “ball and socket” joint. The humeral head abuts and articulates with the glenoid to provide a wide range of motion. In an unhealthy shoulder joint, the interaction between the glenoid and the humerus is compromised, requiring repair or replacement.


Replacing the glenoid articular surface of the scapula of a human with a prosthetic glenoid component is a delicate surgical operation, notably because of the muscular environment of the shoulder. It is found that, depending on the position of implantation of such a glenoid component, risks of separation of the component from the underlying scapula exist due to forces applied to this component in subsequent movements of the prosthesized shoulder. In particular, in certain patients, it was found that, even if the implantation on their scapula of such a glenoid component was perfectly centered on the articular head of the corresponding humerus on completion of the surgical implantation operation, the resumption of their activities led, more or less rapidly, to instability of the prosthesis.


Currently, several companies are working on custom devices to guide glenoid bone preparation. One example filed by Tornier, Inc. is U.S. patent application Ser. No. 12/954,423, filed 24 Nov. 2010 and published as US 2011/0130795 A1.


SUMMARY

A patient specific glenoid guide is provided to facilitate properly aligned implantation of a glenoid prosthesis into a patient. The guide shape is designed preoperatively based on the unique configuration of the scapula of the patient. The guide orientation is chosen preoperatively based on one or more of the bone structure of the patient, the wear pattern of the patient's glenoid cavity, the anchoring means of the glenoid prosthesis, or other aspects.


The guide may reversibly snap into securement with the scapula of the patient to hold the guide to the scapula during surgery. The guide may establish one or more axes through the shoulder joint about which subsequent bone preparation procedures and prosthesis implantation may be carried out. The guide may allow insertion of one or more K-wires or pins through the guide and into the scapula along the axis, and also allow removal of the guide without removing the one or more K-wires or pins.


The patient specific glenoid guide may be comprised of a central tubular element and three or more peripheral arms emanating from the central tubular element. One or more arms may terminate in a peripheral peg. One or more peripheral peg may be configured to reversibly engage with the scapula of the patient. The guide may be made by rapid prototyping or three dimensional printing methods.


While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates schematic views of worn shoulder joints.



FIG. 2 illustrates an isometric plan view of a patient specific glenoid guide.



FIG. 3 illustrates a partial cross sectional side view of a patient specific glenoid guide.



FIG. 4A illustrates a partial cross sectional side view of a patient specific glenoid guide.



FIG. 4B illustrates a cross sectional side view of a portion of a patient specific glenoid guide.



FIG. 5 illustrates an isometric plan view of a patient specific glenoid guide attached to a model of a patient's scapula.



FIG. 6 illustrates an isometric plan view of an alternate embodiment of a patient specific glenoid guide.



FIG. 7 illustrates an isometric bottom view of an alternate embodiment of a patient specific glenoid guide.





While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT


FIG. 1 illustrates five examples of worn shoulder joints that can be found in patients in need of shoulder arthroplasty. Each joint is comprised of a humeral head HH and a scapula S. The glenoid joint surface GS of the scapula is worn and can be classified as A1, A2, B1, B2, or C according to the shape of the glenoid surface (“Glenoid morphology in OA: Walch Classification”, Walch G. et. al., J. Arthroplasty, 14:756-760, 1999). A glenoid GS may include a neo-glenoid portion 14 that has a significant amount of erosion and a paleo-glenoid portion 12 that has little or no erosion. Such a glenoid is commonly referred to as a “type-B2” glenoid (J. Bone Joint Surg. Br. 2011 vol. 93-B no. SUPP IV, 571). A prosthetic glenoid component (not shown) can be adapted to be positioned between the scapula and the humeral component. The glenoid component is also adapted to articulate with the humeral component. The humeral component may be a humeral prosthesis secured to the humerus of the subject or an anatomical humeral head of the subject.


As part of the process for restoring a functional articular surface to the scapula a glenoid implant is firmly attached to the scapula by a fixation means (not shown). In some examples the fixation means comprises one or more screws, pegs, keels, fins, cement, or other fixation means. It is desirable to establish proper orientation of the glenoid implant in relation to the scapula and the humerus to assure that the fixation means has adequate strength to resist implant dislodgement from forces generated by articular motions of the joint. For example, screws must have adequate pull-out strength to resist articular forces of the joint that tend to dislodge the implant from the shoulder bones. Further, proper orientation of the glenoid implant in relation to the scapula and the humerus can minimize the forces generated on the glenoid implant during articulation of the shoulder joint. To facilitate proper orientation of the glenoid implant an axis through the shoulder joint can be established and the axis used to properly orient the glenoid implant so as to accomplish the above goals.


Another part of the process for properly fitting a glenoid implant to the scapula can be preparing the worn surface of the scapula so that the prepared surface will match a previously prepared surface of the glenoid implant. A surgeon may need to remove a significant amount of bone including cortical bone of the relatively healthy portions of the glenoid to accommodate typical glenoid implants. When these matched surfaces are brought into apposition the combination will resist rocking, sliding, twisting, and other articular motions of the joint that tend to dislodge the implant from the shoulder bones. To facilitate proper orientation of the glenoid implant an axis through the shoulder joint can be established and the axis used to guide scapula surface preparation tools such as reamers, guides, broaches and other devices so as to accomplish the above goals.



FIGS. 2 and 3 illustrate one embodiment of a patient specific glenoid guide. Guide 100 is a unique structure based on the exact shoulder joint anatomy of a specific patient. Guide 100 is comprised of central tubular element 110, three or more arms 120, and at least three arms each having peripheral peg 130.


Central tubular element 110 is comprised of lumen 112 having axis X-X and is designed to guide a drill bit (not shown) for drilling a hole in the scapula. In another embodiment central tubular element 110 is designed to guide an alignment pin (not shown) through lumen 112 along axis X-X.


In a further embodiment (see FIGS. 4A and 4B) guide 100 is used with commercially available metallic pin guide 114 of a generic design that is not patient specific. Pin guide 114 can be engaged with lumen 112 of central tubular element 110 to hold the two components together during surgery. In one embodiment pin guide is engaged with central tubular element by friction fit. In another embodiment pin guide is engaged with central tubular element by locking conical tapers, in one example Morse tapers. Specific dimensions (in mm) of central tubular element 110 for one locking taper embodiment are illustrated in FIG. 4B, and pin guide 114 external mating dimensions are the same as the internal mating dimensions of the central tubular element. Typically pin guide 114 is long enough to function as a handle during surgery for placement of guide 100.


At least three arms 120 are provided on the guide, four arms are preferred, and 5, 6, 7, or 8 arms are contemplated. The arms between the central tubular element and each peripheral peg may have an elliptical, round, ovoid, polygonal, square, rectangular, triangular, other cross-section. In one embodiment the arm has an elliptical cross section and the major axis of the ellipse is perpendicular to the glenoid surface, the major axis is about 5 mm in length and the minor axis is about 4 mm in length. Arm 120 has a cross sectional area 122. Arm cross sectional areas of 10 square millimeters to 40 square millimeters and any cross sectional area therebetween are contemplated.


Peripheral peg 130 is comprised of identifier 132 and engagement surface 134. At least three pegs are provided on the guide, four pegs are preferred, and 5, 6, 7, or 8 pegs are contemplated. Three pegs are positioned to engage the anterior border of the glenoid cavity while one peg is positioned to engage the supero-posterior border of the glenoid cavity. Opposite to peg engagement surface 134, on the peg lateral extremity, the pegs are marked with identifier 132. In some embodiments anterior pegs are marked with identifier “A” while posterior pegs are marked with identifier “P”. Peg diameters of 6 mm to 10 mm and any diameter therebetween are contemplated. In one embodiment peg diameter is 8 mm. In another embodiment the posterior peg axis P-P is angled at an obtuse angle α from the arm so as to not be in conflict with the posterior retractor during the arthroplasty procedure. Engagement surface 134 may be customized to closely conform to the 3 dimensional shape of the border of the glenoid cavity.


Patient specific glenoid guide 100 optionally comprises handle 116 (FIG. 6). Handle 116 is long enough to function as a handle during surgery for placement of guide 100. Also, use of handle 116 instead of pin guide 114 for manipulation of guide 100 allows a short drill bit to be used through central tubular element 110 rather than a long drill bit through the combination of central tubular element 110 plus drill guide 114.


Patient specific glenoid guide 100 optionally comprises strut 140 having slot 142 (FIG. 7). The slot rotational position along the central axis X-X of the guide is the one of the supero-inferior axis of the glenoid component as determined by the pre-operative planning. Slot 142 is optionally used by the surgeon to mark this axis on the patient's bone with electrocautery.


In a further embodiment (not shown), second guide 100′ is associated with first guide 100. Second guide 100′ is similar to first guide 100 except that second guide 100′ is designed to fit the patient's scapula after the scapula shape has been modified, for example, modified by reaming, and central tubular element 110′ is comprised of two or more lumens 112′, 112″ having axes parallel to axis X-X. In some embodiment's lumens 112′, 112″ may be used to guide a drill bit (not shown) for drilling at least 2 holes in the scapula.


Guide 100 can be made by molding, machining, casting, thermal forming, or by other methods. In one embodiment guide 100 is made by rapid prototyping techniques, additive manufacturing or three dimensional printing using methods such as stereolithography or laser sintering. Guide 100 can be comprised of thermoplastics such as polyamide (such as PA2200 by Arptech) or metals such as titanium or stainless steel, or other materials.


Guide 100 is designed from three dimensional (3D) data about the anatomy of a patient's shoulder. The position and orientation of the axis X-X of the central tubular element 110 is defined according to pre-operative planning. The design process reproduces the translational positions of the glenoid component on three axes, (the antero-posterior axis, the supero-inferior axis and the medio-lateral axis) and it also reproduces the rotational positions of the glenoid component around the same three axes (supero-inferior axis (version), antero-posterior axis (inclination), and the medio-lateral axis (rotation)). By visualizing all of these positions a best choice position and orientation of axis X-X can be selected before operating on the patient. Also, a variety of glenoid implants can be evaluated for compatibility and performance in relation to the patients specific anatomy.


In one exemplar embodiment a three dimensional model of the patients shoulder is generated from imaging data obtained using a medical imaging technique such as a CT scan or a MRI. The imaging data are processed manually or automatically to generate a 3D model of the patient's scapula. From the 3D model of the patient's scapula, patient-specific guide 100 is designed automatically or manually using various CAD programs and/or software available such as Solid Works or ProEngineer.

    • a. As a first step in this example the 3D model of the bone is displayed in a specific environment in which the surgeon is able to select the desired implant and to place it at the desired location and desired orientation in the 3D model of the patient's scapula. Alternatively the implant could be automatically selected and/or placed based on a set of pre-determined criteria such as those described in EP2324801A1 or US2011/0119884 A1 which are incorporated herein in their entirety and can be found in the Appendix.
    • b. As a second step in this example, once the implant is selected and placed in position in the 3D model of the patient's scapula the location of the pegs is determined by the surgeon or by an engineer. Then the guide structure, including central tubular element 110, arms 120, pegs 130, and all of their features as described above, is manually or automatically generated. A dilatation of 2 pixels of the outside dimensions of the scapula is applied to bone model, and therefore to the guide engagement surface, in order to get a proper fit between the guide and the bone model as well as between the guide and the native bone.
    • c. The patient-specific guide 100 so generated will have a three dimensional engagement surface at the distal end of each peg that is complementary and made to conformingly contact the anatomical surface of the glenoid cavity border. The patient-specific guide 100 is thereby configured to fit at a unique position to the anatomical surface of the scapula. The central element of the guide so generated is in the proper location and orientation for proper location of the glenoid implant.
    • d. Optionally a 3D bone model 210 of the patient's scapula can be produced from the 3D imaging data, and said model can be provided to the surgeon with guide 100 as part of an implant kit 200 (FIG. 5). Such a model will allow the surgeon to test the fit and orientation of the guide 100 against the model of the patient's scapula prior to surgery, and can be a reference for the surgeon during surgery.


A non-limiting exemplar method of use of the patient specific glenoid guide is now described.

    • a. A patient undergoes a medical imaging technique such as a CT scan or a MRI and the imaging datum are processed manually or automatically to generate a 3D model of the patient's scapula.
    • b. The 3D model of the scapula is displayed in a specific environment in which the surgeon selects the desired implant and places it at the desired location and desired orientation in the 3D model of the patient's scapula. Alternatively the implant is automatically selected and/or placed based on a set of pre-determined criteria such as those described in EP2324801A1 or US2011/0119884 A1 which are incorporated herein in their entirety and can be found in the Appendix.
    • c. The location of 4 pegs is determined by the surgeon or by an engineer.
    • d. The guide structure, including central tubular element 110, arms 120, pegs 130, and all of their features as described above, is manually or automatically generated. A dilatation of 2 pixels of the outside dimensions of the scapula is applied to bone model, and therefore to the guide engagement surface, in order to get a proper fit between the guide and the bone model as well as between the guide and the native bone.
    • e. Optionally a 3D bone model of the patient's scapula is produced from the 3D imaging data.
    • f. The glenoid guide is provided to the surgeon. Optionally, a kit comprised of the 3D bone model and glenoid guide is provided to the surgeon.
    • g. The surgeon exposes the glenoid cavity of the patient.
    • h. The glenoid guide is pressed onto the border of the glenoid cavity and engages the glenoid in a snap fit attachment.
    • i. Pin placement through lumen 112 of guide 110 into patients scapula is performed.
    • j. Guide 110 is removed from the pin.
    • k. Scapula surface preparation and/or glenoid prosthesis placement is performed using pin as a guide.
    • l. Pin is removed.
    • m. Remainder of shoulder arthroplasty procedure is completed.


Terminology

Conditional language, such as “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, and/or steps. Thus, such conditional language is not generally intended to imply that features, elements, and/or steps are in any way required for one or more embodiments.


The term “about” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result. For example, the term “about” may refer to an amount that is within less than 10% of the stated amount, as the context may dictate.


Any methods disclosed herein need not be performed in the order recited. The methods disclosed herein include certain actions taken by a practitioner; however, they can also include any third-party instruction of those actions, either expressly or by implication. For example, actions such as “positioning three pegs around an anterior anatomical feature adjacent of the a glenoid cavity” include “instructing the positioning of three pegs around an anterior anatomical feature adjacent of the a glenoid cavity.”


Although certain embodiments and examples have been described herein, it will be understood by those skilled in the art that many aspects of the glenoid guide shown and described in the present disclosure may be differently combined and/or modified to form still further embodiments or acceptable examples. All such modifications and variations are intended to be included herein within the scope of this disclosure. A wide variety of designs and approaches are possible. No feature, structure, or step disclosed herein is essential or indispensable.


Some embodiments have been described in connection with the accompanying drawings. However, it should be understood that the figures are not drawn to scale. Distances, angles, etc. are merely illustrative and do not necessarily bear an exact relationship to actual dimensions and layout of the devices illustrated. Components can be added, removed, and/or rearranged. Further, the disclosure herein of any particular feature, aspect, method, property, characteristic, quality, attribute, element, or the like in connection with various embodiments can be used in all other embodiments set forth herein. Additionally, it will be recognized that any methods described herein may be practiced using any device suitable for performing the recited steps.


For purposes of this disclosure, certain aspects, advantages, and novel features are described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment. Thus, for example, those skilled in the art will recognize that the disclosure may be embodied or carried out in a manner that achieves one advantage or a group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.


Moreover, while illustrative embodiments have been described herein, the scope of any and all embodiments having equivalent elements, modifications, omissions, combinations (e.g., of aspects across various embodiments), adaptations and/or alterations as would be appreciated by those in the art based on the present disclosure. The limitations in the claims are to be interpreted broadly based on the language employed in the claims and not limited to the examples described in the present specification or during the prosecution of the application, which examples are to be construed as non-exclusive. Further, the actions of the disclosed processes and methods may be modified in any manner, including by reordering actions and/or inserting additional actions and/or deleting actions. It is intended, therefore, that the specification and examples be considered as illustrative only, with a true scope and spirit being indicated by the claims and their full scope of equivalents.


Example Embodiments

The following example embodiments identify some possible permutations of combinations of features disclosed herein, although other permutations of combinations of features are also possible.


1. A patient specific glenoid guide for attachment to a scapula of a patient, the glenoid guide comprising:

    • a guide feature;
    • at least three arms having a first end coupled with the guide feature and a second end disposed away from the guide feature; and
    • at least three peripheral pegs, each peripheral peg extending from the second end of a corresponding arm and comprising an engagement surface;
    • wherein the engagement surface is configured to engage the scapula of the patient to provide a snap fit attachment onto the scapula.


2. The patient specific glenoid guide of Embodiment 1, wherein the guide feature comprises a central tubular element that comprises a lumen.


3. The patient specific glenoid guide of Embodiment 1 or 2, wherein the guide feature is tapered.


4. The patient specific glenoid guide of any one of Embodiments 1 to 3, wherein the guide feature is configured to receive a pin guide.


5. The patient specific glenoid guide of any one of Embodiments 1 to 4, wherein the at least three peripheral pegs comprises four peripheral pegs.


6. The patient specific glenoid guide of Embodiment 5, wherein three of the four peripheral pegs are configured to engage an anterior anatomical feature of the scapula, and wherein one of the four peripheral pegs is configured to engage a supero-posterior anatomical feature of the scapula.


7. The patient specific glenoid guide of Embodiment 6, wherein three of the four peripheral pegs are configured to engage an anterior border of a glenoid cavity, and wherein one of the four peripheral pegs is configured to engage a supero-posterior border of the glenoid cavity.


8. The patient specific glenoid guide of any one of Embodiments 1 to 7, wherein each of the at least three arms comprises an elliptical cross section, the major axis of the elliptical cross-section being perpendicular to a glenoid cavity when the glenoid guide is coupled with the scapula.


9. The patient specific glenoid guide of any one of Embodiments 1 to 8, wherein an angle between one of the at least three arms and a corresponding peg is an obtuse angle.


10. The patient specific glenoid guide of any one of Embodiments 1 to 9, further comprising a lateral handle extending laterally from the guide feature.


11. The patient specific glenoid guide of any one of Embodiments 1 to 10, further comprising a strut extending laterally from the guide feature, the strut comprising a slot.


12. A system for guiding a glenoid prosthesis, the system comprising:

    • the glenoid guide of any one of Embodiments 1 to 11; and
    • a pin guide configured to engage the guide feature.


13. The system of Embodiment 12, wherein the pin guide comprises a tapered surface, and wherein the guide feature is tapered to receive the tapered pin guide.


14. A surgical kit comprising:

    • a patient specific glenoid guide, the glenoid guide comprising:
    • a guide feature;
    • a plurality of arms extending from the guide feature; and
    • a plurality of peripheral pegs, each of the plurality of peripheral pegs extending from a corresponding arm, each of the plurality of peripheral pegs comprising an engagement surface; and
    • a three dimensional model of a patient's scapula comprising a glenoid cavity border; and
    • wherein the engagement surfaces of the patient specific glenoid guide are configured to engage the glenoid cavity border of the model by a snap fit.


15. The surgical kit of Embodiment 14, wherein the guide feature comprises a central tubular element that comprises a lumen.


16. The surgical kit of Embodiment 14 or 15, wherein the guide feature is tapered.


17. The surgical kit of any one of Embodiments 14 to 16, wherein the guide feature is configured to receive a pin guide.


18. The surgical kit of any one of Embodiments 14 to 17, wherein the plurality of peripheral pegs comprises four peripheral pegs.


19. The surgical kit of Embodiment 18, wherein three of the four peripheral pegs are configured to engage an anterior portion of the glenoid cavity border, and wherein one of the four peripheral pegs is configured to engage a supero-posterior portion of the glenoid cavity border.


20. The surgical kit of any one of Embodiments 14 to 19, wherein each of the plurality of arms comprises an elliptical cross section, the major axis of the elliptical cross-section being perpendicular to a portion of the model corresponding to a glenoid cavity when the guide is applied to the model.


21. The surgical kit of any one of Embodiments 14 to 20, wherein an angle between one of the plurality of peripheral pegs and the corresponding arms is an obtuse angle.


22. The surgical kit of any one of Embodiments 14 to 21, further comprising a lateral handle extending laterally from the guide feature.


23. The surgical kit of any one of Embodiments 14 to 22, further comprising a strut extending laterally from the guide feature, the strut comprising a slot.


24. The surgical kit of any one of Embodiments 14 to 23, further comprising a pin guide coupled to the guide feature.


25. A method of guiding a glenoid prosthesis, the method comprising:

    • pre-operatively determining a position and an orientation of guide feature of a glenoid guide based on a specific patient's scapula, the glenoid guide comprising:
    • a plurality of arms extending from the guide feature; and
    • a peripheral peg extending from each of the plurality of arms, the guide feature disposed inward of the peripheral pegs;
    • engaging the glenoid guide with the scapula;
    • inserting a pin having an axis through the guide feature to or through the scapula.


26. The method of Embodiment 25, wherein the guide feature comprises a central tubular element that comprises a lumen and inserting the pin comprises inserting the pin through the lumen of the guide feature.


27. The method of Embodiment 25 or 26, wherein engaging the glenoid guide with the scapula comprises engaging the glenoid guide with a glenoid cavity border by snap fit.


28. The method of any one of Embodiments 25 to 27, wherein engaging the glenoid guide with the scapula comprises positioning three pegs around an anterior anatomical feature of a glenoid cavity and positioning one peg at a supero-posterior anatomical feature of the glenoid cavity.


29. The method of Embodiment 28, wherein engaging the glenoid guide with the scapula comprises positioning three pegs around an anterior anatomical border of the glenoid cavity and positioning one peg at a supero-posterior border of the glenoid cavity.


30. The method of any one of Embodiments 25 to 29, further comprising advancing the glenoid prosthesis along the pin.


31. The method of any one of Embodiments 25 to 30, further comprising securing the pin to the guide feature by a friction fit.


32. The method of any one of Embodiments 25 to 30, further comprising securing a conical taper of the pin with a conical taper of the guide feature.

Claims
  • 1. A method of guiding a glenoid prosthesis, the method comprising: pre-operatively determining a position and an orientation of a guide feature of a glenoid guide based on a scapula of a specific patient, the glenoid guide comprising: the guide feature that comprises a tapered lumen configured to receive a pin guide, wherein the lumen defining a central axis;at least four arms, each arm having a first end coupled with the guide feature and a second end disposed away from the guide feature such that each of the at least four arms extends radially outwardly from the guide feature;at least four peripheral pegs, each peripheral peg including a lateral end being coupled to the second end of a corresponding one of the at least four arms and comprising an engagement surface at a medial end, the engagement surface configured to engage the scapula of the patient, wherein first three peripheral pegs are positioned to engage anterior border of a glenoid cavity of the patient and fourth peg is positioned to engage supero-posterior border of the glenoid cavity; anda strut extending radially from the guide feature, the strut comprising a slot and positioned at a rotational position along the central axis so that the slot's rotational position along the central axis corresponds to a supero-inferior axis of the glenoid prosthesis;engaging the glenoid guide with the scapula such that each of the engagement surfaces contacts the border of the glenoid cavity and the at least four arms are spaced apart from a lateral surface of the glenoid; andinserting a pin having an axis through the tapered lumen to or through the scapula.
  • 2. The method of claim 1, wherein the guide feature is a central tubular element that comprises the tapered lumen and inserting the pin through the guide feature comprises inserting the pin through the lumen.
  • 3. The method of claim 1, wherein engaging the glenoid guide with the scapula comprises engaging the glenoid guide with a glenoid cavity border by snap fit.
  • 4. The method of claim 1, wherein engaging the glenoid guide with the scapula comprises positioning the first three peripheral pegs around an anterior anatomical feature of the glenoid cavity and positioning the fourth peripheral peg at a supero-posterior anatomical feature of the glenoid cavity.
  • 5. The method of claim 4, wherein the anterior anatomical feature of the glenoid cavity is an anterior anatomical border of the glenoid cavity and the supero-posterior anatomical feature of the glenoid cavity is a supero-posterior border of the glenoid cavity.
  • 6. The method of claim 1, further comprising advancing the glenoid prosthesis along the pin.
  • 7. The method of claim 1, further comprising securing the pin to the guide feature by a friction fit.
  • 8. The method of claim 1, further comprising securing a conical taper of the pin with a conical taper of the guide feature.
  • 9. The method of claim 1, further comprising engaging a pin guide with the tapered lumen first before inserting the pin.
  • 10. A method of guiding a glenoid prosthesis, the method comprising: pre-operatively determining a position and an orientation of a guide feature of a glenoid guide based on a specific patient's scapula, the glenoid guide comprising: a guide feature configured to receive a pin guide;a plurality of arms, each arm having a first end coupled with the guide feature and a second end disposed away from the guide feature such that each arm of the plurality of arms extends radially outwardly from the guide feature; anda plurality of peripheral pegs, wherein each peripheral peg includes a lateral end being coupled to the second end of a corresponding one of the plurality of arms and comprising an engagement surface at a medial end, the engagement surface configured to conform to a three dimensional shape of a glenoid cavity border of the scapula of the patient, wherein the guide feature comprises a tapered lumen configured to receive the pin guide;engaging the glenoid guide with the scapula such that each of the engagement surfaces contacts the border of the glenoid cavity and the plurality of arms are spaced apart from a lateral surface of the glenoid;inserting a pin having an axis through the guide feature to or through the scapula.
  • 11. The method of claim 10, wherein the guide feature is a central tubular element that comprises a tapered lumen and inserting the pin through the guide feature comprises inserting the pin through the tapered lumen.
  • 12. The method of claim 10, wherein engaging the glenoid guide with the scapula comprises engaging the glenoid guide with a glenoid cavity border by snap fit.
  • 13. The method of claim 10, wherein engaging the glenoid guide with the scapula comprises positioning three peripheral pegs around an anterior anatomical feature of the glenoid cavity and positioning a fourth peripheral peg at a supero-posterior anatomical feature of the glenoid cavity.
  • 14. The method of claim 13, wherein the anterior anatomical feature of the glenoid cavity is an anterior anatomical border of the glenoid cavity and the supero-posterior anatomical feature of the glenoid cavity is a supero-posterior border of the glenoid cavity.
  • 15. The method of claim 10, further comprising advancing the glenoid prosthesis along the pin.
  • 16. The method of claim 10, further comprising securing the pin to the guide feature by a friction fit.
  • 17. The method of claim 10, further comprising securing a conical taper of the pin with a conical taper of the guide feature.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a divisional of U.S. application Ser. No. 16/521,466, filed on Jul. 24, 2019, which is a divisional of U.S. application Ser. No. 15/024,747, filed on Mar. 24, 2016, now U.S. Pat. No. 10,405,993, which is a national phase of PCT International Application No. PCT/IB2014/002711, filed on Nov. 11, 2014, which claims priority benefit under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 61/903,814, filed on Nov. 13, 2013, both of which are incorporated by reference in their entirety herein. Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.

US Referenced Citations (661)
Number Name Date Kind
4919670 Dale et al. Apr 1990 A
5030219 Matsen, III et al. Jul 1991 A
5329846 Bonutti Jul 1994 A
5370692 Fink et al. Dec 1994 A
5383938 Rohr et al. Jan 1995 A
5531793 Kelman et al. Jul 1996 A
5610966 Martell et al. Mar 1997 A
5725586 Sommerich Mar 1998 A
5768134 Swaelens et al. Jun 1998 A
5769856 Dong et al. Jun 1998 A
5779710 Matsen, III Jul 1998 A
5807437 Sachs et al. Sep 1998 A
5824078 Nelson et al. Oct 1998 A
5824085 Sahay et al. Oct 1998 A
6002859 DiGioia, III et al. Dec 1999 A
6129764 Servidio Oct 2000 A
6155812 Smith et al. Dec 2000 A
6172856 Jang Jan 2001 B1
6183519 Bonnin et al. Feb 2001 B1
6364910 Shultz et al. Apr 2002 B1
6385475 Cinquin et al. May 2002 B1
6432142 Kamiya et al. Aug 2002 B1
6459948 Ateshian et al. Oct 2002 B1
6648894 Abdelgany et al. Nov 2003 B2
6699289 Iannotti et al. Mar 2004 B2
6719799 Kropf Apr 2004 B1
6772026 Bradbury et al. Aug 2004 B2
6797006 Hodorek Sep 2004 B2
6915150 Cinquin et al. Jul 2005 B2
6944518 Roose Sep 2005 B2
7468075 Lang et al. Dec 2008 B2
7469474 Farrar Dec 2008 B2
7534263 Burdulis, Jr. et al. May 2009 B2
7542791 Mire et al. Jun 2009 B2
7599539 Kunz et al. Oct 2009 B2
7618451 Berez et al. Nov 2009 B2
7634119 Tsougarakis et al. Dec 2009 B2
7648530 Habermeyer et al. Jan 2010 B2
7678150 Tornier et al. Mar 2010 B2
7717956 Lang May 2010 B2
7747305 Dean et al. Jun 2010 B2
7796791 Tsougarakis et al. Sep 2010 B2
7799077 Lang et al. Sep 2010 B2
7802503 Couvillion et al. Sep 2010 B2
7822588 Mueller et al. Oct 2010 B2
7831079 Kunz et al. Nov 2010 B2
7927338 Laffargue et al. Apr 2011 B2
7981158 Fitz et al. Jul 2011 B2
7983777 Melton et al. Jul 2011 B2
8007448 Barrera Aug 2011 B2
8014984 Iannotti et al. Sep 2011 B2
8055487 James Nov 2011 B2
8062302 Lang et al. Nov 2011 B2
8066708 Lang et al. Nov 2011 B2
8077950 Tsougarakis et al. Dec 2011 B2
8083745 Lang et al. Dec 2011 B2
8094900 Steines et al. Jan 2012 B2
8105330 Fitz et al. Jan 2012 B2
8122582 Burdulis, Jr. et al. Feb 2012 B2
8160325 Zug et al. Apr 2012 B2
8160345 Pavlovskaia et al. Apr 2012 B2
8175683 Roose May 2012 B2
8214016 Lavallee et al. Jul 2012 B2
8221430 Park et al. Jul 2012 B2
8231634 Mahfouz et al. Jul 2012 B2
8234097 Steines et al. Jul 2012 B2
8337501 Fitz et al. Dec 2012 B2
8337503 Lian Dec 2012 B2
8337507 Lang et al. Dec 2012 B2
8343218 Lang et al. Jan 2013 B2
8350186 Jones et al. Jan 2013 B2
8366771 Burdulis, Jr. et al. Feb 2013 B2
8377073 Wasielewski Feb 2013 B2
8377129 Fitz et al. Feb 2013 B2
8382765 Axelson et al. Feb 2013 B2
8439926 Bojarski et al. May 2013 B2
8444651 Kunz et al. May 2013 B2
8457930 Schroeder Jun 2013 B2
8460304 Fitz et al. Jun 2013 B2
8475463 Lian Jul 2013 B2
8480753 Collazo et al. Jul 2013 B2
8480754 Bojarski et al. Jul 2013 B2
8500740 Bojarski et al. Aug 2013 B2
8529568 Bouadi Sep 2013 B2
8529630 Bojarski et al. Sep 2013 B2
8532806 Masson Sep 2013 B1
8532807 Metzger Sep 2013 B2
8535319 Ball Sep 2013 B2
8545509 Park et al. Oct 2013 B2
8545569 Fitz et al. Oct 2013 B2
8551099 Lang et al. Oct 2013 B2
8551102 Fitz et al. Oct 2013 B2
8551103 Fitz et al. Oct 2013 B2
8551169 Fitz et al. Oct 2013 B2
8556906 Fitz et al. Oct 2013 B2
8556907 Fitz et al. Oct 2013 B2
8556971 Lang Oct 2013 B2
8556983 Bojarski et al. Oct 2013 B2
8561278 Fitz et al. Oct 2013 B2
8562611 Fitz et al. Oct 2013 B2
8562618 Fitz et al. Oct 2013 B2
8568479 Fitz et al. Oct 2013 B2
8568480 Fitz et al. Oct 2013 B2
8585708 Fitz et al. Nov 2013 B2
8608749 Meridew et al. Dec 2013 B2
8617172 Fitz et al. Dec 2013 B2
8617242 Philipp Dec 2013 B2
8623026 Wong et al. Jan 2014 B2
8634617 Tsougarakis et al. Jan 2014 B2
8634618 Zug et al. Jan 2014 B2
8638998 Steines et al. Jan 2014 B2
8641716 Fitz et al. Feb 2014 B2
8657827 Fitz et al. Feb 2014 B2
8663333 Metcalfe et al. Mar 2014 B2
8682052 Fitz et al. Mar 2014 B2
8690945 Fitz et al. Apr 2014 B2
8709089 Lang et al. Apr 2014 B2
8731885 Iannotti et al. May 2014 B2
8734455 Park et al. May 2014 B2
8735773 Lang May 2014 B2
8744148 Nord et al. Jun 2014 B2
8764836 De Wilde et al. Jul 2014 B2
8768028 Lang et al. Jul 2014 B2
8771365 Bojarski et al. Jul 2014 B2
8774900 Buly et al. Jul 2014 B2
8775133 Schroeder Jul 2014 B2
8777875 Park Jul 2014 B2
8801719 Park et al. Aug 2014 B2
8808302 Roose et al. Aug 2014 B2
8814942 Anthony et al. Aug 2014 B2
8830233 Friedland et al. Sep 2014 B2
8843229 Vanasse et al. Sep 2014 B2
8864769 Stone et al. Oct 2014 B2
8864834 Boileau et al. Oct 2014 B2
8882847 Burdulis, Jr. et al. Nov 2014 B2
8884618 Mahfouz Nov 2014 B2
8888855 Roche et al. Nov 2014 B2
8898043 Ashby et al. Nov 2014 B2
8903530 Metzger Dec 2014 B2
8906107 Bojarski et al. Dec 2014 B2
8926706 Bojarski et al. Jan 2015 B2
8932361 Tornier et al. Jan 2015 B2
8932363 Tsougarakis et al. Jan 2015 B2
8934961 Lakin et al. Jan 2015 B2
8945230 Lang et al. Feb 2015 B2
8951259 Fitz et al. Feb 2015 B2
8951260 Lang et al. Feb 2015 B2
8965088 Tsougarakis et al. Feb 2015 B2
8971606 Chaoui Mar 2015 B2
8974539 Bojarski et al. Mar 2015 B2
8984731 Broeck et al. Mar 2015 B2
8986309 Murphy Mar 2015 B1
8989460 Mahfouz Mar 2015 B2
8990052 Lavallee et al. Mar 2015 B2
8992533 Blain et al. Mar 2015 B2
8992538 Keefer Mar 2015 B2
8998915 Fitz et al. Apr 2015 B2
9011456 Ranawat et al. Apr 2015 B2
9020788 Lang Apr 2015 B2
9023050 Lang et al. May 2015 B2
9055953 Lang et al. Jun 2015 B2
9060788 Bollinger Jun 2015 B2
9066728 Burdulis, Jr. et al. Jun 2015 B2
9066806 Phipps Jun 2015 B2
9072531 Fitz et al. Jul 2015 B2
9084617 Lang et al. Jul 2015 B2
9095353 Burdulis, Jr. et al. Aug 2015 B2
9095375 Haimerl et al. Aug 2015 B2
9107679 Lang et al. Aug 2015 B2
9107680 Fitz et al. Aug 2015 B2
9113921 Lang et al. Aug 2015 B2
9125672 Fitz et al. Sep 2015 B2
9126673 Green et al. Sep 2015 B1
9138258 Geebelen Sep 2015 B2
9180015 Fitz et al. Nov 2015 B2
9186161 Lang et al. Nov 2015 B2
9186254 Fitz et al. Nov 2015 B2
9198732 Iannotti et al. Dec 2015 B2
9204977 Bollinger Dec 2015 B2
9211199 Ratron Dec 2015 B2
9216025 Fitz et al. Dec 2015 B2
9220516 Lang et al. Dec 2015 B2
9220517 Lang et al. Dec 2015 B2
9232955 Bonin, Jr. et al. Jan 2016 B2
9237950 Hensley et al. Jan 2016 B2
9241724 Lang et al. Jan 2016 B2
9241725 Lang et al. Jan 2016 B2
9278413 Sperling Mar 2016 B2
9289221 Gelaude et al. Mar 2016 B2
9295481 Fitz et al. Mar 2016 B2
9295482 Fitz et al. Mar 2016 B2
9301768 Buza et al. Apr 2016 B2
9301812 Kehres et al. Apr 2016 B2
9308005 Fitz et al. Apr 2016 B2
9308053 Bojarski et al. Apr 2016 B2
9308091 Lang Apr 2016 B2
9314256 Fitz et al. Apr 2016 B2
9320608 Sperling Apr 2016 B2
9320620 Bojarski et al. Apr 2016 B2
9326780 Wong et al. May 2016 B2
9326862 Smith et al. May 2016 B2
9333085 Fitz et al. May 2016 B2
9345548 Schoenefeld et al. May 2016 B2
9351743 Kehres et al. May 2016 B2
9358018 Fitz et al. Jun 2016 B2
9381025 Fitz et al. Jul 2016 B2
9381026 Trouilloud et al. Jul 2016 B2
9386994 Agnihotri et al. Jul 2016 B2
9387083 Al Hares et al. Jul 2016 B2
9402726 Linderman et al. Aug 2016 B2
9408615 Fitz et al. Aug 2016 B2
9408616 Kehres et al. Aug 2016 B2
9408686 Miller et al. Aug 2016 B1
9408698 Miles et al. Aug 2016 B2
9414928 Sperling Aug 2016 B2
9421021 Keppler Aug 2016 B2
9439767 Bojarski et al. Sep 2016 B2
9451973 Heilman et al. Sep 2016 B2
9486226 Chao Nov 2016 B2
9495483 Steines et al. Nov 2016 B2
9498233 Eash Nov 2016 B2
9498344 Hodorek et al. Nov 2016 B2
9504579 Mahfouz et al. Nov 2016 B2
9517134 Lang Dec 2016 B2
9539013 Katrana et al. Jan 2017 B2
9554910 Vanasse et al. Jan 2017 B2
9575931 Ratron Feb 2017 B2
9579106 Lo et al. Feb 2017 B2
9579110 Bojarski et al. Feb 2017 B2
9592128 Phipps Mar 2017 B2
9597201 Bollinger Mar 2017 B2
9603711 Bojarski et al. Mar 2017 B2
9615834 Agnihotri et al. Apr 2017 B2
9615840 Iannotti et al. Apr 2017 B2
9636229 Lang et al. May 2017 B2
9646113 Park et al. May 2017 B2
9649170 Park et al. May 2017 B2
9662214 Li et al. May 2017 B2
9668873 Winslow et al. Jun 2017 B2
9675461 Mahfouz Jun 2017 B2
9675471 Bojarski et al. Jun 2017 B2
9681956 Al Hares et al. Jun 2017 B2
9684768 Lavallee et al. Jun 2017 B2
9687945 Steines et al. Jun 2017 B2
9693785 Theiss et al. Jul 2017 B2
9700420 Fitz et al. Jul 2017 B2
9700971 Lang Jul 2017 B2
9713533 Taylor et al. Jul 2017 B2
9713539 Haimerl et al. Jul 2017 B2
9715563 Schroeder Jul 2017 B1
9717508 Iannotti et al. Aug 2017 B2
9737367 Steines et al. Aug 2017 B2
9741263 Iannotti et al. Aug 2017 B2
9757238 Metzger Sep 2017 B2
9763682 Bettenga Sep 2017 B2
9770335 Sperling Sep 2017 B2
9775680 Bojarski et al. Oct 2017 B2
9795393 Hughes et al. Oct 2017 B2
9808261 Gelaude et al. Nov 2017 B2
9814533 Park et al. Nov 2017 B2
9820868 Witt et al. Nov 2017 B2
9839438 Eash Dec 2017 B2
9849019 Miller et al. Dec 2017 B2
9872773 Lang et al. Jan 2018 B2
9877790 Bojarski et al. Jan 2018 B2
9895230 Mahfouz Feb 2018 B2
9913691 Brooks Mar 2018 B2
9913723 Fitz et al. Mar 2018 B2
9925048 Winslow et al. Mar 2018 B2
9936962 Heilman et al. Apr 2018 B2
9937046 Mahfouz Apr 2018 B2
9943370 Asseln et al. Apr 2018 B2
9956047 Bojarski et al. May 2018 B2
9956048 Bojarski et al. May 2018 B2
9987024 Frey et al. Jun 2018 B2
9993341 Vanasse et al. Jun 2018 B2
10010334 Keppler Jul 2018 B2
10010431 Eraly et al. Jul 2018 B2
10019551 Zellner et al. Jul 2018 B2
10085839 Wong et al. Oct 2018 B2
10433969 Humphrey Oct 2019 B2
10537390 Varadarajan et al. Jan 2020 B2
10548737 Hodorek et al. Feb 2020 B2
10722310 Luby Jul 2020 B2
10736697 Chaoui et al. Aug 2020 B2
10762623 Geebelen et al. Sep 2020 B2
10842510 Heilman et al. Nov 2020 B2
10842512 Bonin, Jr. et al. Nov 2020 B2
10888378 Walch Jan 2021 B2
10905562 Sbaiz et al. Feb 2021 B2
10912571 Pavlovskaia et al. Feb 2021 B2
10922448 McKinnon et al. Feb 2021 B2
10925658 Hopkins Feb 2021 B2
10973535 Iannotti et al. Apr 2021 B2
10973580 Berend et al. Apr 2021 B2
11033335 Zhang Jun 2021 B2
11039889 Frey et al. Jun 2021 B2
11051830 Jaramaz et al. Jul 2021 B2
11071592 McGuan et al. Jul 2021 B2
11083525 Varadarajan et al. Aug 2021 B2
11090161 Hodorek Aug 2021 B2
11129678 Park Sep 2021 B2
11134963 Buza et al. Oct 2021 B2
11141276 Kehres Oct 2021 B2
11166733 Neichel et al. Nov 2021 B2
11166764 Roh et al. Nov 2021 B2
11179249 Deransart et al. Nov 2021 B2
11185417 Boileau et al. Nov 2021 B2
11202675 Uhde et al. Dec 2021 B2
11213305 Iannotti et al. Jan 2022 B2
11234721 Gargac et al. Feb 2022 B2
11253323 Hughes et al. Feb 2022 B2
11278299 Neichel et al. Mar 2022 B2
11278413 Lang Mar 2022 B1
11298118 Koo Apr 2022 B1
11298140 Wilkinson et al. Apr 2022 B2
11298142 Park et al. Apr 2022 B2
11298188 Kehres et al. Apr 2022 B2
11298189 Kelman et al. Apr 2022 B2
11337762 McKinnon et al. May 2022 B2
11344370 Park et al. May 2022 B2
11364127 Deransart et al. Jun 2022 B2
11399851 Neichel et al. Aug 2022 B2
11399894 Chaoui et al. Aug 2022 B2
11410769 Yildirim Aug 2022 B1
11419618 Kehres et al. Aug 2022 B2
11419680 Kontaxis et al. Aug 2022 B2
11432931 Lang Sep 2022 B2
11432934 Couture et al. Sep 2022 B2
11443846 Schoenefeld et al. Sep 2022 B2
11471303 Christopher Oct 2022 B2
11488721 Otto et al. Nov 2022 B2
11490965 Bischoff et al. Nov 2022 B2
11490966 Roche et al. Nov 2022 B2
11559403 Kehres Jan 2023 B2
11596479 McGuan et al. Mar 2023 B2
11602360 Heilman et al. Mar 2023 B2
11617591 Eash Apr 2023 B2
11621086 Spångberg et al. Apr 2023 B2
11622818 Siemionow et al. Apr 2023 B2
11653976 Bonny et al. May 2023 B2
11660197 Lang May 2023 B1
11696833 Casey et al. Jul 2023 B2
11712302 Walch Aug 2023 B2
11717412 Casey et al. Aug 2023 B2
11730497 Iannotti et al. Aug 2023 B2
11737883 Metcalfe et al. Aug 2023 B2
11751946 Gangwar et al. Sep 2023 B2
11752000 Terrill Sep 2023 B2
11766268 Iannotti et al. Sep 2023 B2
11766336 Penninger et al. Sep 2023 B2
11819415 Metcalfe et al. Nov 2023 B2
11847755 Park et al. Dec 2023 B2
11850158 Simoes et al. Dec 2023 B2
11883040 Bonin, Jr. et al. Jan 2024 B2
20010047210 Wolf Nov 2001 A1
20020007294 Bradbury et al. Jan 2002 A1
20020082741 Mazumder et al. Jun 2002 A1
20030028253 Stone et al. Feb 2003 A1
20030074080 Murray Apr 2003 A1
20030139818 Rogers et al. Jul 2003 A1
20040039259 Krause et al. Feb 2004 A1
20040064189 Maroney et al. Apr 2004 A1
20040102866 Harris et al. May 2004 A1
20040133276 Lang et al. Jul 2004 A1
20040138754 Lang et al. Jul 2004 A1
20040171924 Mire et al. Sep 2004 A1
20040181144 Cinquin et al. Sep 2004 A1
20040199258 Macara Oct 2004 A1
20040236424 Berez et al. Nov 2004 A1
20040243481 Bradbury et al. Dec 2004 A1
20050049709 Tornier Mar 2005 A1
20050065617 Barrera et al. Mar 2005 A1
20050065628 Roose Mar 2005 A1
20050087047 Farrar Apr 2005 A1
20050098915 Long et al. May 2005 A1
20050112397 Rolfe et al. May 2005 A1
20050197814 Aram Sep 2005 A1
20050216305 Funderud Sep 2005 A1
20060079963 Hansen Apr 2006 A1
20060095047 de la Barrera May 2006 A1
20060136058 Pietrzak Jun 2006 A1
20060161167 Myers et al. Jul 2006 A1
20070089518 Ericson et al. Apr 2007 A1
20070118055 McCombs May 2007 A1
20070118243 Schroeder et al. May 2007 A1
20070173945 Wiley et al. Jul 2007 A1
20070191741 Tsai et al. Aug 2007 A1
20070198022 Lang et al. Aug 2007 A1
20070198094 Berelsman et al. Aug 2007 A1
20070203605 Melton et al. Aug 2007 A1
20070233141 Park et al. Oct 2007 A1
20070244563 Roche et al. Oct 2007 A1
20070249967 Buly et al. Oct 2007 A1
20080014082 Kunz et al. Jan 2008 A1
20080109000 Maroney et al. May 2008 A1
20080140209 Iannotti et al. Jun 2008 A1
20080183297 Boileau et al. Jul 2008 A1
20080228269 McLeod et al. Sep 2008 A1
20080243127 Lang et al. Oct 2008 A1
20080269596 Revie et al. Oct 2008 A1
20080269906 Iannotti et al. Oct 2008 A1
20080281328 Lang et al. Nov 2008 A1
20080281329 Fitz et al. Nov 2008 A1
20080281426 Fitz et al. Nov 2008 A1
20080287954 Kunz et al. Nov 2008 A1
20090089034 Penney et al. Apr 2009 A1
20090099662 Splieth et al. Apr 2009 A1
20090216285 Ek et al. Aug 2009 A1
20090226068 Fitz et al. Sep 2009 A1
20090264894 Wasielewski Oct 2009 A1
20090276045 Lang Nov 2009 A1
20090292464 Fuchs et al. Nov 2009 A1
20090318929 Tornier et al. Dec 2009 A1
20100023015 Park Jan 2010 A1
20100082035 Keefer Apr 2010 A1
20100087927 Roche et al. Apr 2010 A1
20100114326 Winslow et al. May 2010 A1
20100160917 Fitz et al. Jun 2010 A1
20100191100 Anderson et al. Jul 2010 A1
20100217270 Polinski et al. Aug 2010 A1
20100222781 Collazo et al. Sep 2010 A1
20100292963 Schroeder Nov 2010 A1
20100303313 Lang et al. Dec 2010 A1
20100305573 Fitz et al. Dec 2010 A1
20100305574 Fitz et al. Dec 2010 A1
20110029088 Rauscher et al. Feb 2011 A1
20110035013 Winslow et al. Feb 2011 A1
20110040334 Kaes et al. Feb 2011 A1
20110046735 Metzger et al. Feb 2011 A1
20110054478 Vanasse et al. Mar 2011 A1
20110118846 Katrana et al. May 2011 A1
20110119884 Ratron May 2011 A1
20110137427 Lappin et al. Jun 2011 A1
20110152869 Ek et al. Jun 2011 A1
20110166661 Boileau et al. Jul 2011 A1
20110190775 Ure Aug 2011 A1
20110295329 Fitz et al. Dec 2011 A1
20110304332 Mahfouz Dec 2011 A1
20120010711 Antonyshyn et al. Jan 2012 A1
20120041446 Wong et al. Feb 2012 A1
20120041564 Landon Feb 2012 A1
20120078258 Lo et al. Mar 2012 A1
20120101503 Lang et al. Apr 2012 A1
20120116203 Vancraen et al. May 2012 A1
20120130434 Stemniski May 2012 A1
20120141034 Iannotti et al. Jun 2012 A1
20120143267 Iannotti Jun 2012 A1
20120245647 Kunz et al. Sep 2012 A1
20120253350 Anthony et al. Oct 2012 A1
20120253467 Frankle Oct 2012 A1
20120276509 Iannotti et al. Nov 2012 A1
20120279933 Hensler et al. Nov 2012 A1
20120289965 Gelaude et al. Nov 2012 A1
20120290272 Bryan Nov 2012 A1
20120296339 Iannotti et al. Nov 2012 A1
20120303035 Geebelen Nov 2012 A1
20130024580 Tsai et al. Jan 2013 A1
20130053968 Nardini et al. Feb 2013 A1
20130110116 Kehres et al. May 2013 A1
20130110471 Lang et al. May 2013 A1
20130114873 Chaoui May 2013 A1
20130172898 Iannotti et al. Jul 2013 A1
20130190882 Humphrey Jul 2013 A1
20130204375 Winslow et al. Aug 2013 A1
20130211531 Steines et al. Aug 2013 A1
20130261629 Anthony et al. Oct 2013 A1
20130274752 Trouilloud et al. Oct 2013 A1
20130325134 Viscardi et al. Dec 2013 A1
20130338673 Keppler Dec 2013 A1
20140039633 Roche et al. Feb 2014 A1
20140074246 Huebner et al. Mar 2014 A1
20140159282 Smith et al. Jun 2014 A1
20140163564 Bollinger Jun 2014 A1
20140236304 Hodorek et al. Aug 2014 A1
20140257304 Eash Sep 2014 A1
20140257499 Winslow et al. Sep 2014 A1
20140276867 Kelley et al. Sep 2014 A1
20140303938 Schoenefeld et al. Oct 2014 A1
20140303990 Schoenefeld et al. Oct 2014 A1
20140371863 Vanasse et al. Dec 2014 A1
20150045903 Neal Feb 2015 A1
20150052586 Mills Feb 2015 A1
20150093283 Miller et al. Apr 2015 A1
20150105787 Tornier et al. Apr 2015 A1
20150112348 Schoenefeld et al. Apr 2015 A1
20150150688 Vanasse et al. Jun 2015 A1
20150190151 Budhabbatti et al. Jul 2015 A1
20150223941 Lang Aug 2015 A1
20150250552 Radermacher et al. Sep 2015 A1
20150250597 Lang et al. Sep 2015 A1
20150250601 Humphrey Sep 2015 A1
20150265411 Deransart et al. Sep 2015 A1
20150320430 Kehres et al. Nov 2015 A1
20150328004 Mafhouz Nov 2015 A1
20150342739 Mahfouz Dec 2015 A1
20160015466 Park et al. Jan 2016 A1
20160030196 Eraly et al. Feb 2016 A1
20160051367 Gervasi et al. Feb 2016 A1
20160067049 Flaherty et al. Mar 2016 A1
20160074052 Keppler et al. Mar 2016 A1
20160100907 Gomes Apr 2016 A1
20160120555 Bonin, Jr. et al. May 2016 A1
20160136904 Murai et al. May 2016 A1
20160143744 Bojarski et al. May 2016 A1
20160143749 Holovacs et al. May 2016 A1
20160157937 Kehres et al. Jun 2016 A1
20160166392 Vanasse et al. Jun 2016 A1
20160184104 Sperling Jun 2016 A1
20160192951 Gelaude et al. Jul 2016 A1
20160193051 Budhabhatti et al. Jul 2016 A1
20160213385 Iannotti et al. Jul 2016 A1
20160242933 Deransart et al. Aug 2016 A1
20160256222 Walch Sep 2016 A1
20160270854 Chaoui et al. Sep 2016 A1
20160296285 Chaoui et al. Oct 2016 A1
20160296290 Furrer et al. Oct 2016 A1
20160324648 Hodorek et al. Nov 2016 A1
20160331467 Slamin et al. Nov 2016 A1
20160345987 Guilloux et al. Dec 2016 A1
20160374697 Kehres et al. Dec 2016 A1
20170000614 Mahfouz Jan 2017 A1
20170000615 Mahfouz Jan 2017 A1
20170007330 Britton et al. Jan 2017 A1
20170027587 Fraone et al. Feb 2017 A1
20170027593 Bojarski et al. Feb 2017 A1
20170027702 Goldstein et al. Feb 2017 A1
20170035513 Mahfouz et al. Feb 2017 A1
20170056024 Chao Mar 2017 A1
20170056187 Humphrey et al. Mar 2017 A1
20170071748 Humphrey Mar 2017 A1
20170079803 Lang Mar 2017 A1
20170105841 Vanasse et al. Apr 2017 A1
20170105843 Britton et al. Apr 2017 A1
20170112626 Miller et al. Apr 2017 A1
20170119531 Bojarski et al. May 2017 A1
20170143499 Phipps May 2017 A1
20170150978 Iannotti et al. Jun 2017 A1
20170151058 Sperling Jun 2017 A1
20170216038 Lang et al. Aug 2017 A1
20170231783 Lang et al. Aug 2017 A1
20170249440 Lang et al. Aug 2017 A1
20170258598 Radermacher et al. Sep 2017 A1
20170273795 Neichel et al. Sep 2017 A1
20170273800 Emerick et al. Sep 2017 A1
20170273801 Hodorek Sep 2017 A1
20170281357 Taylor et al. Oct 2017 A1
20170296347 Chua et al. Oct 2017 A1
20170304063 Hatzidakis et al. Oct 2017 A1
20170340449 Deransart et al. Nov 2017 A1
20170360567 Fitz et al. Dec 2017 A1
20170367766 Mahfouz Dec 2017 A1
20170367828 Steines et al. Dec 2017 A1
20170367834 Fitz et al. Dec 2017 A1
20180014835 Lo et al. Jan 2018 A1
20180028325 Bojarski et al. Feb 2018 A1
20180036019 Iannotti et al. Feb 2018 A1
20180161176 Vivanz et al. Jun 2018 A1
20180228614 Lang et al. Aug 2018 A1
20180233222 Daley et al. Aug 2018 A1
20180235642 Amis et al. Aug 2018 A1
20180235706 Asseln et al. Aug 2018 A1
20180235762 Radermacher et al. Aug 2018 A1
20180263782 Lang et al. Sep 2018 A1
20180289380 Mauldin et al. Oct 2018 A1
20180325526 Haddad Nov 2018 A1
20190000629 Winslow Jan 2019 A1
20190015113 Morvan Jan 2019 A1
20190015116 Neichel et al. Jan 2019 A1
20190015117 Neichel et al. Jan 2019 A1
20190015118 Neichel et al. Jan 2019 A1
20190015119 Athwal et al. Jan 2019 A1
20190015221 Neichel et al. Jan 2019 A1
20190021866 Vanasse et al. Jan 2019 A1
20190029757 Roh et al. Jan 2019 A1
20190038360 Chaoui Feb 2019 A1
20190069913 Iannotti et al. Mar 2019 A1
20190090952 Bonny et al. Mar 2019 A1
20190142519 Siemionow et al. May 2019 A1
20190175354 Knox et al. Jun 2019 A1
20190201005 Schoenefeld et al. Jul 2019 A1
20190269415 Lo et al. Sep 2019 A1
20190365473 Kehres et al. Dec 2019 A1
20200030034 Kontaxis et al. Jan 2020 A1
20200078180 Casey Mar 2020 A1
20200113632 Varadarajan et al. Apr 2020 A1
20200155323 Lang et al. May 2020 A1
20200170802 Casey Jun 2020 A1
20200188121 Boux De Casson et al. Jun 2020 A1
20200188134 Mullen et al. Jun 2020 A1
20200281728 Kulper et al. Sep 2020 A1
20200289276 Lefebvre et al. Sep 2020 A1
20200330161 Chaoui et al. Oct 2020 A1
20200405330 Bonin, Jr. et al. Dec 2020 A1
20210030477 Zuhars et al. Feb 2021 A1
20210045888 Sbaiz et al. Feb 2021 A1
20210068844 Lo et al. Mar 2021 A1
20210085475 Hodorek et al. Mar 2021 A1
20210128179 Dupuis et al. May 2021 A1
20210128244 Couture et al. May 2021 A1
20210196290 Iannotti et al. Jul 2021 A1
20210228277 Chaoui et al. Jul 2021 A1
20210228371 Deransart et al. Jul 2021 A1
20210228372 Knox et al. Jul 2021 A1
20210259844 Penninger et al. Aug 2021 A1
20210307833 Farley et al. Oct 2021 A1
20210307911 Metcalfe et al. Oct 2021 A1
20210315642 McGuan et al. Oct 2021 A1
20210322130 Penney et al. Oct 2021 A1
20210330389 Varadarajan et al. Oct 2021 A1
20210338435 Hodorek Nov 2021 A1
20210386435 Buza et al. Dec 2021 A1
20220022895 Neichel et al. Jan 2022 A1
20220031475 Deransart et al. Feb 2022 A1
20220047278 Fitz et al. Feb 2022 A1
20220054197 Plessers et al. Feb 2022 A1
20220096240 Neichel et al. Mar 2022 A1
20220110644 Gargac et al. Apr 2022 A1
20220110685 McGuan et al. Apr 2022 A1
20220125515 McGuan et al. Apr 2022 A1
20220148454 Jaramaz et al. May 2022 A1
20220160376 Neichel et al. May 2022 A1
20220160405 Casey et al. May 2022 A1
20220160439 Ryan et al. May 2022 A1
20220183757 Caldera et al. Jun 2022 A1
20220202497 Janna et al. Jun 2022 A1
20220211507 Simoes et al. Jul 2022 A1
20220249168 Besier et al. Aug 2022 A1
20220257321 Kehres et al. Aug 2022 A1
20220273450 Steines et al. Sep 2022 A1
20220287850 Daudet Sep 2022 A1
20220296259 Shah Sep 2022 A1
20220313440 Metcalfe et al. Oct 2022 A1
20220330957 Neichel et al. Oct 2022 A1
20220338933 Metcalfe et al. Oct 2022 A1
20220338998 Sperling Oct 2022 A1
20220346968 Pettersson et al. Nov 2022 A1
20220351828 Chaoui Nov 2022 A1
20220354658 Knox et al. Nov 2022 A1
20220370142 Schoenefeld et al. Nov 2022 A1
20220387110 Chaoui Dec 2022 A1
20220395376 Poon et al. Dec 2022 A1
20230000645 Christopher Jan 2023 A1
20230045575 Lang et al. Feb 2023 A1
20230048940 Kontaxis et al. Feb 2023 A1
20230061695 Couture et al. Mar 2023 A1
20230079807 Metcalfe et al. Mar 2023 A1
20230085093 Chaoui et al. Mar 2023 A1
20230109478 Chaoui et al. Apr 2023 A1
20230139531 Roche et al. May 2023 A1
20230148085 Paul et al. May 2023 A1
20230181257 McGuan et al. Jun 2023 A1
20230248435 Bonny et al. Aug 2023 A1
20230317298 Spångberg et al. Oct 2023 A1
20230329791 Chaoui et al. Oct 2023 A1
20230346397 Iannotti et al. Nov 2023 A1
20230346480 Walch Nov 2023 A1
20230355401 Metcalfe et al. Nov 2023 A1
20230363915 Metcalfe et al. Nov 2023 A1
20230372018 Gangwar et al. Nov 2023 A1
20230372111 Terrill Nov 2023 A1
Foreign Referenced Citations (90)
Number Date Country
2021203700 Aug 2023 AU
2927086 Apr 2015 CA
2927811 Apr 2015 CA
2938709 May 2015 CA
3203261 Jul 2022 CA
1 249 213 Oct 2002 EP
1 265 555 Dec 2002 EP
1 563 810 Aug 2005 EP
1 862 151 Dec 2007 EP
1 902 689 Mar 2008 EP
1 952 788 Aug 2008 EP
2 135 576 Dec 2009 EP
1 917 051 Jun 2010 EP
2 243 445 Oct 2010 EP
2 324 801 May 2011 EP
2 501 313 Sep 2012 EP
2 544 601 Jan 2013 EP
2583242 Apr 2013 EP
1858430 Oct 2013 EP
2471483 Oct 2013 EP
2670314 Aug 2014 EP
2 845 547 Mar 2015 EP
2 965 720 Jan 2016 EP
1323395 Aug 2016 EP
3057518 Aug 2016 EP
3057524 Aug 2016 EP
3065671 Sep 2016 EP
3068317 Sep 2016 EP
2 874 570 Jan 2017 EP
3 117 801 Jan 2017 EP
2244654 Mar 2017 EP
2770920 Jul 2017 EP
2770919 Aug 2017 EP
2303192 Nov 2018 EP
3760142 Jan 2021 EP
3248553 Mar 2021 EP
3845154 Jul 2021 EP
3481318 Sep 2022 EP
2 579 454 Oct 1986 FR
2 859 099 Mar 2005 FR
2962573 Jan 2012 FR
2982694 Nov 2016 FR
2982979 Nov 2016 FR
2982693 Dec 2016 FR
2501494 Oct 2013 GB
3179628 Nov 2012 JP
WO 93025157 Dec 1993 WO
WO 0035346 Jun 2000 WO
WO 0059411 Oct 2000 WO
WO 02061688 Aug 2002 WO
2005016123 Feb 2005 WO
WO-2006106419 Oct 2006 WO
2008021494 Feb 2008 WO
2008117028 Oct 2008 WO
WO 2010120346 Oct 2010 WO
WO 2011110374 Sep 2011 WO
2011142998 Nov 2011 WO
WO 2011154891 Dec 2011 WO
WO 2011157961 Dec 2011 WO
WO 2012021241 Feb 2012 WO
WO 2012058349 May 2012 WO
WO 2012125319 Sep 2012 WO
2012141790 Oct 2012 WO
2012170376 Dec 2012 WO
WO 2013060851 May 2013 WO
WO 2013062848 May 2013 WO
WO 2013062851 May 2013 WO
WO-2013060851 May 2013 WO
WO 2013142998 Oct 2013 WO
WO 2014020561 Feb 2014 WO
WO 2014035991 Mar 2014 WO
2014145267 Sep 2014 WO
WO 2014180972 Nov 2014 WO
2015018921 Feb 2015 WO
WO 2015052586 Apr 2015 WO
WO 2015056097 Apr 2015 WO
2015071757 May 2015 WO
WO 2015068035 May 2015 WO
WO 2015071757 May 2015 WO
WO 2015175397 Nov 2015 WO
WO 2015185219 Dec 2015 WO
WO 2017091657 Jun 2017 WO
WO 2017105815 Jun 2017 WO
WO 2017106294 Jun 2017 WO
WO 2017184792 Oct 2017 WO
WO 2017214537 Dec 2017 WO
WO 2018022227 Feb 2018 WO
WO 2019014278 Jan 2019 WO
WO 2019014281 Jan 2019 WO
WO 2019033037 Feb 2019 WO
Non-Patent Literature Citations (90)
Entry
US 9,451,972 B2, 09/2016, Lang et al. (withdrawn)
Communication Pursuant to Article 94(3) issued in connection with European Patent Application No. 19759204.1, dated May 9, 2023, 6 pages.
Boileau, et al., “The three-dimensional geometry of the proximal humerus: implications for surgical technique and prosthetic design.” The Journal of bone and joint surgery. British vol. 79.5 (1997): 857-865.
Habets, et al., Computer assistance in orthopaedic surgery. Technische Universiteit Eindhoven, 2002.
Hempfing, et al. “Surgical landmarks to determine humeral head retrotorsion for hemiarthroplasty in fractures.” Journal of shoulder and elbow surgery 10.5 (2001): 460-463.
Ma, et al., “Robust registration for computer-integrated orthopedic surgery: laboratory validation and clinical experience.” Medical image analysis 7.3 (2003): 237-250.
“Olympia Total Shoulder System Surgical Technique”, Wright Medical Technology, 2001, in 19 pages.
Radermacher, K., et al., “Computer Assisted Orthopaedic Surgery with Image Based Individual Templates,” Clinical Orthopaedics and Related Research, No. 354, Sep. 1998, pp. 28-38.
Radermacher, K., et al., “Image Guided Orthopedic Surgery Using Individual Templates: Experimental Results and Aspects of the Development of a Demonstrator for Pelvis Surgery”, Health Care Sector, Telematics Applications Program, 1997, pp. 606-615.
Tornier, “Salto Talaris, Total Ankle Prosthesis”, 2009.
Valstar, et al. “Towards computer-assisted surgery in shoulder joint replacement.” ISPRS journal of photogrammetry and remote sensing 56.5-6 (2002): 326-337.
Valstar, et al. “The use of Roentgen stereophotogrammetry to study micromotion of orthopaedic implants.” ISPRS journal of photogrammetry and remote sensing 56.5-6 (2002): 376-389.
Welsh, et al., “CT-based preoperative analysis of scapula morphology and glenohumeral joint geometry.” Computer Aided Surgery 8.5 (2003): 264-268.
Zimmer, “Zimmer® PSI Shoulder Trabecular MetalTM Reverse Glenoid Base Plate Surgical Technique”, Dec. 30, 2013.
Extended European Search Report issued in EP Application No. 18187134.4, dated Nov. 22, 2018 in 6 pages.
International Search Report and Written Opinion for PCT/IB2014/002711 dated Mar. 23, 2015 in 12 pages.
Dougherty, “Digital Image Processing for Medical Applications,” May 11, 2009 (May 11, 2009), Cambridge University Press, XP002615721.
Gregory, et al.,“Accuracy of Glenoid Component Placement in Total Shoulder Arthroplasty and Its Effect on Clinical and Radiological Outcome in a Retrospective, Longitudinal, Monocentric Open Study,” PLOS One, p. e75791, Aug. 1, 2013, vol. 8, No. 10.
Iannotti et al., “Prosthetic positioning in total shoulder arthroplasty,” Journal of Shoulder and Elbow Surgery, Jan. 1, 2005, vol. 14, No. 1S, pp. S111-S121.
Kobashi et al., “Knowledge-Based Organ Identification from CT Images,” Pattern Recognition, Elsevier, GB, vol. 28, No. 4, Apr. 1, 1995 (Apr. 1, 1995), pp. 475-491, XP004013165.
Lee, C.C. et al., “Identifying multiple abdominal organs from CT image series using a multimodule contextual neural network and spatial fuzzy rules”, IEEE Transactions on Information Technology in Biomedicine, IEEE Services Center, Los Alamitos, CA, US, vol. 7, No. 3, Sep. 1, 2003 (Sep. 1, 2003) pp. 208-217, XP011100536.
Wu, et al. “An interface for the data exchange between CAS and CAD/CAM systems.” International Congress Series. vol. 1256. Elsevier, 2003.
Non-Final Office Action issued in connection with U.S. Appl. No. 16/904,345, filed Feb. 15, 2022, 35 pages.
First Office Action issued in corresponding Japanese Patent Application No. 2021-506973, dated Jun. 5, 2023, 5 pages.
Non-Final Office Action issued in connection with U.S. Appl. No. 16/910,663, filed Dec. 15, 2022, 9 pages.
Non-Final Office Action issued in connection with U.S. Appl. No. 17/359,745, Nov. 26, 2023, 7 pages.
Final Office Action issued in connection with U.S. Appl. No. 16/910,663, Nov. 16, 2023, 9 pages.
Communication Pursuant to Article 94(3) issued in connection with European Patent Application No. 18746503.4, Oct. 17, 2023, 5 pages.
Non-Final Office Action issued in connection with U.S. Appl. No. 17/650,722, Nov. 15, 2023, 10 pages.
Notice of Allowance issued in connection with U.S. Appl. No. 17/645,607, Dec. 20, 2023, 11 pages.
Notice of Allowance issued in connection with U.S. Appl. No. 16/648,128, Feb. 16, 2024, 9 pages.
First Examination Report from counterpart Australian Application No. 2021201702 dated Dec. 1, 2021, 2 pp.
Marker et al., “Contour-Based Surface Reconstruction using Implicit Curve Fitting, and Distance Field Filtering and Interpolation,” vol. Graphics, Jan. 2006, 9 pp.
Nguyen et al., “Design and Development of a Computer Assisted Glenoid Implantation Technique for Shoulder Replacement Surgery,” Computer Aided Surgery, vol. 12, No. 3, May 2007, pp. 152-159.
First Examination Report issued in connection with corresponding Australian Patent Application No. 2019236696, Jun. 18, 2020, 4 pages.
International Search Report and Written Opinion of the International Searching Authority issued for PCT Application No. PCT/IB2014/002759 mailed Mar. 27, 2015, 13 pp.
Notice of Acceptance from counterpart Australian Application No. 2021201702 dated Apr. 1, 2022, 3 pp.
Notice of Allowance from counterpart Canadian Application No. 2,927,811 dated Jan. 18, 2022, 1 pp.
Office Action from counterpart Canadian Application No. 2,927,811, dated Apr. 29, 2021, 3 pp.
Office Action from counterpart Canadian Application No. 2,927,811, dated Nov. 17, 2020, 3 pp.
Office Action issued in connection with corresponding Canadian Patent Application No. 2,927,811, May 25, 2020, 3 pages.
Prosecution History from U.S. Appl. No. 15/029,879, dated May 17, 2018 through Dec. 16, 2020, 122 pp.
Prosecution History from U.S. Appl. No. 17/117,546, dated Dec. 10, 2020 through Mar. 14, 2023, 29 pp.
Raaijmakers et al., “A Custom-Made Guide-Wire Positioning Device for Hip Surface Replacement Arthroplasty: Description and First Results,” BMC Musculoskeletal Disorders, vol. 11, Jul. 2010, 7 pp.
Response to Office Action dated Dec. 1, 2021, from counterpart Australian Application No. 2021201702 filed Mar. 30, 2022, 1 pp.
Response to Official Action from counterpart Canadian Application No. 2,927,811, dated Apr. 29, 2021, filed Aug. 26, 2021, 8 pp.
Response to Official Action from counterpart Canadian Application No. 2,927,811, dated May 25, 2020, filed Sep. 25, 2020, 19 pp.
Response to Official Action from counterpart Canadian Application No. 2,927,811, dated Nov. 17, 2020, filed Mar. 16, 2021, 15 pp.
Response to Official Action from counterpart Canadian Application No. 2,927,811, dated Oct. 10, 2019, filed Apr. 14, 2020, 11 pp.
Advisory Action from U.S. Appl. No. 16/918,347 dated Aug. 8, 2023, 2 pp.
Boissonnat, J.D., “Shape Reconstruction from Planar Cross Sections,” Computer Vision, Graphics, and Image Processing, vol. 44, No. 1, Oct. 1988, 29 pp.
Communication pursuant to Article 94(3) EPC from counterpart European Application No. 19209711.1 dated Dec. 21, 2022, 4 pp.
Examination Report No. 1 from counterpart Australian Application No. 2021203700 dated Dec. 1, 2022, 5 pp.
Extended European Search Report issued in connection with corresponding European Patent Application No. 19209711.1; 12 pages, Mar. 23, 2020.
Final Office Action from U.S. Appl. No. 16/918,347 dated May 30, 2023, 18 pp.
First Examination Report from counterpart Australian Patent Application No. 2021209349 dated Oct. 6, 2022, 4 pp.
First Examination Report issued in connection with Australian Patent Application No. 2019236759 Jul. 17, 2020, 5 pages.
International Preliminary Report on Patentability from International Application No. PCT/IB2014/002819, dated Apr. 12, 2016, 12 pp.
International Search Report and Written Opinion of the International Searching Authority issued for PCT Application PCT/IB2014/002819 mailed on May 8, 2015.
Notice of Acceptance from counterpart Australian Application No. 2019236759, dated Apr. 27, 2021, 114 pp.
Notice of Acceptance from counterpart Australian Application No. 2021203700, dated Aug. 14, 2023, 41 pp.
Notice of Allowance from counterpart Canadian Application No. 2,927,086, dated Jul. 22, 2021, 1 pp.
Notice of Allowance from U.S. Appl. No. 16/918,347 dated Oct. 2, 2023, 2 pp.
Notice of Allowance from U.S. Appl. No. 16/918,347 dated Sep. 21, 2023, 8 pp.
Notice of Allowance from U.S. Appl. No. 17/874,452 dated Dec. 4, 2023, 5 pp.
Notice of Allowance from U.S. Appl. No. 17/874,452 dated Nov. 15, 2023, 8 pp.
Notice of Allowance from U.S. Appl. No. 17/874,472 dated Feb. 16, 2024, 18 pp.
Notice of Intent to Grant from counterpart Australian Application No. 2021209349 dated May 12, 2023, 3 pp.
Office Action from U.S. Appl. No. 16/918,347 dated Oct. 21, 2022, 19 pp.
Office Action issued in connection with Canadian Patent Application No. 2,927,086, Jan. 20, 2021, 3 pages.
Office Action issued in connection with corresponding Canadian Patent Application No. 2,927,086, Oct. 16, 2019, 7 pages.
Office Action issued in connection with European Patent Application No. 19209711.1, Dec. 22, 2020, 5 pages.
Prosecution History from Australian Patent Application No. 2014333516, dated May 6, 2016 through Oct. 31, 2019, 290 pp.
Prosecution History from European Patent Application No. 14830864.6, dated Jan. 27, 2015 through Dec. 12, 2019, 307 pp.
Prosecution History from U.S. Appl. No. 15/028,497, dated Apr. 4, 2018 through Apr. 6, 2020, 103 pp.
Prosecution History from U.S. Appl. No. 17/229,111, dated Jul. 16, 2021 through Apr. 1, 2022, 53 pp.
Response to Communication from counterpart European Application No. 19209711.1, dated Dec. 22, 2020, filed Mar. 24, 2021, 14 pp.
Response to Communication pursuant to Article 94(3) EPC dated Dec. 21, 2022, from counterpart European Application No. 19209711.1 filed Apr. 20, 2023, 25 pp.
Response to European Search Report from counterpart European Application No. 19209711.1, dated Mar. 23, 2020, filed Oct. 22, 2020, 8 pp.
Depuy, “Delta CTA Reverse Shoulder Prosthesis” Surgical Technique, Aug. 2004, 28 pages.
Boileau, et al., “Grammont Reverse Prosthesis: Design, Rationale, and Biomechanics”, J. Shoulder Elbow Surg, Jan./Feb. 2005, 15 pages.
Frankle, et al., “Glenoid Morphology in Reverse Shoulder Arthroplasty: Classification and Surgical Implications”, Journal of Shoulder and Elbow Surgery, 2009, 18, pp. 874-885, 12 pages.
Nguyen, et al., “Design and Development of a Computer Assisted Glenoid Implantation Technique for Shoulder Replacement Surgery”, Computer Aided Surgery, May 2007; 12(3): 152-159, 8 pages.
Botha, Charl. P., “Technical Report: Devide—The Delft Visualisation and Image Processing Development Environment”, May 30, 2005, 59 pages.
Botha, et al., “Pre-Operative Planning and Intra-Operative Guidance for Shoulder Replacement Surgery”, Scientific Visualization: Advanced Concepts, pp. 179-195, 1998, 17 pages.
Botha, Charl. P., “Techniques and Software Architectures for Medical Visualisation and Image Processing”, ASCI Dissertation Series No. 117, Sep. 12, 2005, 190 pages.
Krekel, et al., “Evaluation of Bone Impingement Prediction in Pre-Operative Planning for Shoulder Arthroplasty”, Proc. IMechE. vol. 223 Part H: J. Engineering in Medicine, Oct. 14, 2008, 10 pages.
Valstar, et al. “Towards Computer-Assisted Surgery in Shoulder Joint Replacement”, ISPRS Journal of Photogrammety & Remote Sensing 56 (2002) pp. 326-337, May 3, 2002, 12 pages.
Extended European Search Report issued in connection with European Patent Application No. 24162840.3, Jun. 21, 2024, 11 pages.
Non-Final Office Action issued in connection with U.S. Appl. No. 17/643,436, May 22, 2024, 13 pages.
Related Publications (1)
Number Date Country
20220031475 A1 Feb 2022 US
Provisional Applications (1)
Number Date Country
61903814 Nov 2013 US
Divisions (2)
Number Date Country
Parent 16521466 Jul 2019 US
Child 17451499 US
Parent 15024747 US
Child 16521466 US